Symbicort Turbuhaler 30/60 Clinical Experience Investigation
Symbicort Turbuhaler 30/60 Clinical Experience Investigation
The purpose of this study is to confirm the safety (ADR related to beta stimulant drugs, unexpected ADRs) and efficacy of Symbicort in daily practice and the control status on bronchial asthma and Patient satisfaction
Inclusion Criteria:
Exclusion Criteria:
-
Ehime, Ehime, Japan
Gunma, Gunma, Japan
Hokkaido, Hokkaido, Japan
Hyogo, Hyōgo, Japan
Ibaraki, Ibaraki, Japan
Ishikawa, Ishikawa-ken, Japan
Kagawa, Kagawa-ken, Japan
Miyagi, Miyagi, Japan
Shiga, Shiga, Japan
Shimane, Shimane, Japan